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Diabetes Care in American Samoa (DCAS) was a randomized
controlled trial  of a 12-month intervention facilitated by com-
munity  health  workers  (CHWs)  that  demonstrated  improved
HbA1c levels compared with usual care at trial completion. We
sought to evaluate the long-term impact of this intervention on
diabetes control.
Methods
We retrospectively collected HbA1c measurements from medical
records of DCAS participants (n = 268). The study group received
the intervention during the trial, and the control group received the
intervention after the trial. We used mixed-effects longitudinal re-
gression models to assess change in HbA1c within each trial arm
during 3 time periods: DCAS (12 months of the study group’s in-
tervention), the first year after DCAS (control group’s interven-
tion), and the second year after DCAS. Models were adjusted for
baseline characteristics that differed significantly for participants
with a low number of HbA1c measurements from those with a
high number of HbA1c measurements.
Results
After adjustment for confounders, the experiment group experi-
enced a decrease in HbA1c of 0.28 units per year (95% confid-
ence interval [CI], −0.64 to 0.07) during DCAS (intervention).
HbA1c decreased by 0.88 units per year (95% CI, −1.31 to  −0.45)
during the year after the intervention. No significant change was
observed the following year. HbA1c of the control group did not
significantly change during DCAS (usual care) but decreased by
1.31 units per year (95% CI, −1.72 to  −0.91) during its interven-
tion. During the year after the control group’s intervention, HbA1c
increased by 1.18 units per year (95% CI, 0.42 to 1.93).
Conclusion
Both groups had initial improvements in glycemic control, but
HbA1c later plateaued or increased. These results suggest that
time-limited CHW programs improve diabetes control in the short
term, but ongoing programs are needed for sustained impact.
Introduction
Levels of type 2 diabetes in the US Territory of American Samoa
are among the highest in the world, with an estimated prevalence
of 21.5% in 2002 among adults aged 18 or older (1). The high pre-
valence of diabetes is associated with lifestyle changes accompa-
nying economic modernization, including reduced physical activ-
ity and a shift to imported and highly processed foods (2,3). Fur-
thermore,  as  a  medically  underserved area  with  a  shortage  of
health professionals (4), American Samoa has limited health re-
sources available for diabetes management.
Diabetes Care in American Samoa (DCAS) was a randomized
controlled trial of a 12-month diabetes education and support pro-
gram, culturally adapted for American Samoa and delivered by a
team comprising a trained nurse and community health workers
(CHWs).  The experiment  group was  compared with  a  control
group who received usual care and who also received the interven-
tion after the study ended. At trial completion, HbA1c, a measure
of average blood glucose, was 0.53 units lower in the experiment
group than in the control group after we adjusted for confounders
(5).
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Most programs that use CHWs in diabetes care are time-limited
(median duration: 6 months), and few follow up with participants
long-term (6,7). The results of this study contribute to evidence
supporting  the  effectiveness  of  CHWs in  diabetes  care  (7–9).
However, little is known about whether short-term improvements
in diabetes control are sustained after CHW interventions are over
(8).
Here, we report the longer-term impact of our 12-month CHW in-
tervention on diabetes control. Our objective was to evaluate the
change in HbA1c by trial arm for 3 consecutive 1-year periods
(Figure 1). We hypothesized that HbA1c would increase over time
in the experiment group after the intervention ended. For the con-
trol group, we expected HbA1c to decrease during the interven-
tion and increase after its completion.
Figure 1. Timeline of study analysis. Change in HbA1c over time was evaluated
by trial arm during 3 consecutive 1-year periods: 1) DCAS period; 2) first year
after  DCAS  completion;  and  3)  second  year  after  DCAS  completion.
Abbreviation: DCAS, Diabetes Care in American Samoa.
 
Methods
Study design, setting, and participants
DCAS was a cluster randomized controlled trial conducted in Tu-
tuila, the main island in American Samoa. Details are discussed
elsewhere (5). Briefly, the study design and intervention was adap-
ted from Project Sugar 2, a nurse-CHW team intervention for dia-
betes management for African Americans in Baltimore, Maryland
(9,10). DCAS participants were drawn from the patient popula-
tion of Tafuna Clinic, a federally qualified community health cen-
ter. Villages within the clinic’s catchment area were divided into
12 areas. To limit contamination, villages were randomized to the
experiment or control group on the basis of size and location so
that intervention and usual-care villages were not adjacent. As part
of the study design, the control group also received the CHW in-
tervention following the completion of the trial.
DCAS participants  were  enrolled  by  Tafuna  Clinic  staff  on  a
rolling basis from February 2009 to May 2010. Eligibility criteria
were broad to test real-world effectiveness: aged 18 or older, res-
ident in service area, self-identified as Samoan, type 2 diabetes
diagnosed by a physician, mentally competent and able to give in-
formed consent, unlikely to leave American Samoa for more than
4 months during the study, and having no serious comorbid condi-
tions (eg, end-stage renal disease, cancer). Because recruitment
initially yielded fewer patients with diagnosed diabetes than ex-
pected, Tafuna Clinic providers extended the criteria to include
newly diagnosed patients after community diabetes screenings and
confirmation of diabetes diagnosis.
Our study sample comprised all 268 participants who were en-
rolled in DCAS: 104 assigned to the experiment group and 164 to
the control group (Figure 2). The primary outcome measure was
HbA1c,  collected retrospectively  from the  medical  records  of
DCAS participants. After the parent study (DCAS trial) ended,
medical  records  were  used because additional  study measure-
ments could not be collected in person.
Figure 2. Consolidated Standards of Reporting Trial (CONSORT) diagram of
recruitment. In this intent-to-treat analysis, participants who did not complete
12-month  follow-up  were  included  in  analysis  until  date  of  ineligibility.
Abbreviations:  CHW,  community  health  worker;  DCAS,  Diabetes  Care  in
American Samoa.
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Because the control group received the intervention after the ex-
periment group did, it was not possible to use a randomized design
for this follow-up study. Therefore,  each group was compared
with itself over time. All study protocols and informed consent
procedures were approved by the institutional review boards of the
American Samoa Department of Health and Brown University.
DCAS intervention
The DCAS staff consisted of a nurse care manager and 4 CHWs.
CHWs were recruited from the community through the Tafuna
Clinic employee hiring system; the position required a high school
education with some health care experience preferred. All CHWs
were trained by study investigators, including a primary care phys-
ician, registered nurse and diabetes educator, and behavioral inter-
ventionist. Training included research practice, standards of care
including American Diabetes  Association guidelines  (11),  the
chronic  care  model  (12),  and patient-centered communication
skills (13). CHWs were further certified in diabetes knowledge
and in procedures for taking blood glucose, blood pressure, and
height and weight measurements.
Study participants were classified into 1 of 3 risk profiles, which
determined intervention frequency and intensity.  Risk profiles
were based on an algorithm that  used HbA1c,  blood pressure,
smoking status,  alcohol use,  and Patient  Health Questionnaire
(PHQ-9) depression scores measured at study enrollment. BMI
was not included in the risk profile, given that 93.5% of American
Samoans are overweight or obese (14). Low-risk participants re-
ceived a one-on-one home CHW visit every 3 months, moderate-
risk participants received a one-on-one CHW home visit monthly,
and high-risk participants had weekly group meetings with the
nurse care manager and CHW, or one-on-one meetings with a
CHW if they were unavailable for group meetings.
Intervention content included 8 possible topics chosen from the
American Association of Diabetes Educators’ selected self-care
behaviors: diabetes introduction, healthy eating, physical activity,
medication adherence, monitoring blood glucose and blood pres-
sure,  reducing risk,  healthy coping,  and problem-solving (15).
Topic selection was guided by the risk profile and self-selected
goals of the participants. CHWs used flipcharts including sections
on each of the 8 topics to facilitate diabetes education during vis-
its with participants. Flipcharts were modeled on the National Dia-
betes Education Program flipcharts for diabetes prevention and ad-
apted for the local cultural context (16,17). Given the intervention
time frame and limited scope of the CHWs’ training, weight loss
was not directly targeted but indirectly addressed by topics such as
healthy eating and physical activity.
Data collection
At DCAS enrollment, information was collected on sociodemo-
graphic variables (eg, age, sex), biological measures (eg, HbA1c,
BMI, blood pressure), behavioral measures (eg, diet, exercise),
and psychosocial measures (eg, personal beliefs on diabetes con-
trol).  After  this  baseline assessment,  the experiment group re-
ceived the 12-month CHW intervention while the control group
received usual care, including any regularly scheduled primary
care appointments. The biological, behavioral, and psychosocial
measures of both groups were assessed 12 months after baseline
assessment.  After the follow-up assessment,  the control  group
began  receiving  the  CHW intervention.  The  data  collected  at
baseline and 12 months after baseline were not collected again at
the end of the control group’s intervention.
For this study on diabetes control over time, HbA1c measure-
ments were collected retrospectively from the medical records of
DCAS participants from the period between DCAS enrollment
and June through August 2013. Because of rolling enrollment, the
period of data collection after the experiment arm and the control
arm completed the intervention ranged from 12.5 to 28.0 months
for the control group and 32.9 to 41.2 months for the experiment
group. HbA1c measurements were abstracted from 2 sources: 1)
paper medical records at Tafuna Clinic and 2) the Computerized
Patient Record System at Lyndon B. Johnson (LBJ) Tropical Med-
ical Center, the only hospital in American Samoa, which provides
emergency, acute, and specialty care. Although participants may
have also obtained care at one of the other community health cen-
ters on the island or outside American Samoa, it is unlikely, given
the great distances involved in getting such care.
Statistical analysis
To determine whether there were any confounding factors related
to  frequency  of  HbA1c  measurement,  we  compared  baseline
demographic, biological, behavioral, and psychosocial variables of
participants who had a low number of HbA1c measurements with
those of participants who had a high number of measurements
within each trial arm, including the baseline and 12-month follow-
up HbA1c levels measured as part of the DCAS trial. Differences
were assessed between participants with less than 3 versus 3 or
more HbA1c measurements during DCAS; almost all participants
had at least 2 measurements taken as part of the trial. During sub-
sequent periods, differences were assessed between participants
with less than 2 versus 2 or more HbA1c measurements. Because
demographic variables, risk classification, and comorbid condi-
tions were measured only once (at DCAS enrollment), these en-
rollment measures were used in the analyses of data from all peri-
ods. For all other variables, DCAS enrollment measurements were
used in the DCAS period analysis, and the 12-month follow-up
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measurements were used in the analyses of subsequent periods.
Nonparametric and parametric tests were used as appropriate (eg, t
test or Wilcoxon rank-sum test for continuous variables and χ2 or
Fisher’s exact test for categorical variables). The mean number of
HbA1c measurements by period was also calculated for each trial
arm.
We used mixed-effects longitudinal regression models to assess
whether HbA1c levels changed over time, separately for each trial
arm, during each of the three 1-year periods described previously.
Models were controlled for all baseline variables that were found
to be significantly different between participants with a low num-
ber of HbA1c measurements and those with a high number in any
period. Age was included as a covariate in all models because of
its relationship with diabetes control. All models included random
intercepts to account for within-subject correlation between re-
peated outcomes over time, and standard errors were adjusted to
account for the 2-level clustering of households within villages.
All models used an intent-to-treat analysis, including data from all
participants randomized at DCAS enrollment until the date of loss
to follow-up or discontinuation of care. All analyses were conduc-
ted in Stata version 12.1 (StataCorp, College Station, Texas) us-
ing command xtmixed with two-tailed α = 0.05.
Results
Of eligible participants, 86% were enrolled in DCAS, and the trial
had a 91% retention rate, with no difference in loss-to-follow-up
between the experiment and control groups. Nine participants in
the experiment group were lost to follow-up, and 16 in the control
group during DCAS (Figure 2). For our analysis, the follow-up
period was 3 years from DCAS enrollment (2 years postinterven-
tion completion for the experiment group and 1 year postinterven-
tion completion for the control group).
Baseline characteristics
For both trial arms, mean age was 55 (SD, 12.7) years, 62% were
female, 41% were unemployed, and mean years of education was
12.5 (SD, 2.2). Sociodemographic variables were similar for the
experiment and control groups, with the exception of church at-
tendance location; a greater percentage of participants in the ex-
periment group attended church in a village randomized to the op-
posite trial arm. Church attendance was recorded to measure po-
tential contamination between trial arms because participants in
opposite trial arms who attended the same church may have dis-
cussed their participation in the study with each other. Clinical
characteristics (HbA1c, risk group, BMI, blood pressure, waist cir-
cumference,  and  comorbid  conditions)  were  similar  for  both
groups. The mean baseline HbA1c level for both trial arms was
9.8 (SD, 2.2). Baseline characteristics by trial arm are fully repor-
ted elsewhere (5).
In the experiment group, participants with 3 or more HbA1c meas-
urements during the DCAS (intervention) period had higher mean
HbA1c level at DCAS enrollment and were more likely to be in
the high-risk group than participants with fewer than 3 HbA1c
measurements (Table 1). During the first year after intervention
completion, participants with 2 or more HbA1c measurements
were less likely to attend church in a village randomized to the
control group, had higher mean diastolic blood pressure at DCAS
enrollment, and had a higher number of primary care visits during
the DCAS period. During the second year after intervention com-
pletion, participants with 2 or more HbA1c measurements had
higher mean BMI and a higher number of primary care visits.
Fewer differences were found between participants in the control
group with a high number of HbA1c measurements and those with
a low number. No differences were statistically significant during
the DCAS (usual care) period, but participants with 2 or more
HbA1c measurements during their intervention period had smal-
ler abdominal circumferences at DCAS follow-up than did parti-
cipants with fewer than 2 HbA1c measurements (Table 2). During
the first year after their intervention completion, participants with
2 or more HbA1c measurements were more likely than those with
fewer than 2 to have a comorbid condition.
HbA1c level over time
For the experiment group, HbA1c decreased during DCAS (inter-
vention), but the effect was not statistically significant (−0.28 units
per year; 95% CI, −0.64 to 0.07) (Table 3). During the first year
after intervention completion, HbA1c of the experiment group de-
creased further by 0.88 units per year (95% CI, −1.31 to −0.45).
No significant change was observed during the second year after
intervention completion (0.18 units per year; 95% CI, −0.77 to
1.13).
For the control group, HbA1c did not significantly change over
time during DCAS (usual care) but decreased by 1.31 units per
year (95% CI, −1.72 to −0.91) during the intervention. During the
first year after the control group’s intervention completion, HbA1c
increased by 1.18 units per year (95% CI, 0.42 to 1.93).
Discussion
We found that the experiment group experienced a nonsignificant
decrease of 0.28 units per year during its intervention period. Not-
ably, our previously published analysis found that the experiment
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group’s mean HbA1c after adjustment for confounding factors
was 0.53 units lower than the control group’s HbA1c at 12-month
follow-up. However, this study does not compare the 2 trial arms
but rather examines the effect of time on each trial arm separately.
Thus, the adjusted point estimate of −0.28 units per year is consist-
ent with our prior analysis, finding an unadjusted decline in mean
HbA1c of 0.3 units from baseline to 12-month follow-up for the
experiment group (5). Furthermore, the upper confidence limit
may be explained by the reduction in statistical power caused by
analyzing each trial  arm separately.  The significant  decline in
HbA1c by 0.88 units during the first year after intervention com-
pletion suggests a continued and stronger effect of the CHW pro-
gram even with no continued CHW contact. During the second
year after intervention completion, HbA1c level stabilized, neither
increasing nor decreasing further.
HbA1c of the control group decreased by 1.31 units during its in-
tervention year, a stronger effect than that observed for the experi-
ment group. Yet, unlike the experiment group, HbA1c levels of
the control group all but rebounded during the year after its inter-
vention completion; the control group did not experience the sus-
tained, but temporary, intervention effect observed in the experi-
ment group. Numerous factors may explain the different effects on
each trial arm. Having already delivered the intervention to the ex-
periment group, the CHWs were more experienced and therefore
perhaps more effective during the control group’s intervention.
Additionally, the control group may have been anticipating their
turn with the intervention, thus increasing their motivation for be-
havioral change. On the other hand, CHWs were no longer closely
supervised by DCAS investigators after the 12-month follow-up
assessment, potentially impairing the long-term impact of the in-
tervention on the control group. Furthermore, after the control
group’s intervention,  the nurse-CHW team was disbanded be-
cause  research funding ended,  perhaps  contributing to  the  in-
crease  in  HbA1c  in  the  year  of  observation  after  the  control
group’s intervention.
The strengths of our study include the follow-up time of 3 years
after DCAS enrollment, given that few studies of culturally appro-
priate diabetes education programs follow participants long-term
(6). Furthermore, the enrollment of 86% of those eligible and 91%
study retention support the generalizability of this study to the
population of diabetes patients in American Samoa; we also be-
lieve these results may be relevant to other resource-poor popula-
tions with high rates of diabetes.
This study had some limitations. First, participants had different
numbers of HbA1c measurements at different frequencies, com-
promising the reliability of this study. Second, given that the con-
trol group received the intervention after the experiment group
did, it was not possible to assess the long-term impact of the inter-
vention using a randomized design. Third, the level of social sup-
port available to participants was not measured and may have in-
fluenced the outcomes of our study. Fourth, participants were not
assessed for changes in eligibility (eg, initiation of dialysis, travel
off-island for more than 4 months) after the completion of the
DCAS trial. Fifth, it is possible that some HbA1c measurements
were  not  documented  in  the  records  from  LBJ  Hospital  and
Tafuna Clinic, but there was no way of determining the complete-
ness or accuracy of the records. Sixth, HbA1c measurements taken
at other facilities or off-island were not collected, but it is unlikely
that many participants received care at other locations given the
distance and cost involved in going to another location. Finally,
this study may not be generalizable to non-Samoan populations,
but we believe the results have relevance for other settings with a
high prevalence of diabetes and low resources. Directions for fu-
ture research include analyzing the long-term impact of the CHW
intervention on health care use and other biologic factors such as
BMI and blood pressure.
This study examined the long-term impact of a 12-month nurse-
CHW intervention on diabetes  control  over  time in  American
Samoa, a resource-poor setting with a high-risk population. Each
trial arm experienced initial improvements in glycemic control
during its intervention period, followed by either an increase or
plateau of HbA1c levels. This study contributes to the literature
that evaluates the effectiveness of CHWs in improving diabetes
outcomes in resource-poor settings and explores the long-term im-
pact of a limited-duration program. Our results suggest that con-
tinued improvements in diabetes control  may require standing
CHW programs fully integrated with traditional health care ser-
vices and strong support of CHWs as members of the health care
team (18,19).
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Tables
Table 1. Baseline Characteristics of Experiment Group by Number of HbA1c Measurements, Diabetes Control Interven-








Number of HbA1c Measurements < 3 ≥ 3 Total < 2 ≥ 2 Total < 2 ≥ 2 Total
Mean no. of HbA1c measurements
(95% CI)
2.8 (2.6–3.0) 1.7 (1.5–1.9) 0.9 (0.7–1.1)
No. of participants 46 58 104 47 48 95 69 26 95
Demographicsc


















Married/with partner, % 82.6 75.9 78.9 78.7 79.2 79.0 76.8 84.6 79.0


















Females, % 60.9 53.5 56.7 55.3 60.4 57.9 63.8 42.3 57.9
Employed, % 46.7 41.4 43.7 55.3 37.5 46.3 44.9 50.0 46.3
Church attendance in opposite trial-
arm village, %d
84.8 75.9 79.8 89.4e 68.8e 79.0 78.3 80.8 79.0
Biological measures




9.6 (2.1) 9.4 (2.0) 9.1 (1.9) 9.3 (1.9) 9.1 (1.9) 9.6 (2.2) 9.3 (1.9)
Current daily smoker, %f 10.9 8.6 10.9 14.9 6.3 10.5 10.1 11.5 10.5
Depression symptoms/Patient health
questionnaire-9, mean (SD)f










Algorithm risk level: low (quarterly visits
by CHW)c
10.9 8.6 10.9 10.6 6.3 8.4 7.3 11.5 8.4
Algorithm risk level: moderate (monthly
visits by CHW)c
63.0e 37.9e 63.0 42.6 58.3 50.5 55.1 38.5 50.5
Algorithm risk level: high (weekly visits
by CHW)c
26.1e 53.5e 26.1 46.8 35.4 41.1 37.7 50.0 41.1




































Abbreviations: CHW, community health worker; CI, confidence interval; DCAS, Diabetes Care in American Samoa; HbA1c, a measure reflecting average
blood glucose; SD, standard deviation.
a Includes baseline and 12-month follow-up HbA1c levels measured as part of DCAS study.
b Includes 12-month follow-up HbA1c levels measured as part of DCAS study.
c Measured at DCAS enrollment.
d Indicator of potential for contamination across trial arms by church attendance.
e Significant difference by HbA1c measurement category, P < .05. Nonparametric and parametric tests were used as appropriate (eg, t test or Wilcoxon
rank-sum test for continuous variables and χ2 or Fisher’s exact test for categorical variables).
f DCAS enrollment measurement used in DCAS study period analyses. DCAS 12-month follow-up measurement used in subsequent time periods.
g Number of primary care visits during one year before DCAS enrollment used in DCAS study period analysis. Number of primary care visits during DCAS
study period used in subsequent time periods.
(continued on next page)
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(continued)
Table 1. Baseline Characteristics of Experiment Group by Number of HbA1c Measurements, Diabetes Control Interven-








Number of HbA1c Measurements < 3 ≥ 3 Total < 2 ≥ 2 Total < 2 ≥ 2 Total
≥ 140 (%)f 32.6 36.2 32.6 25.5 35.4 30.5 27.5 38.5 30.5
Diastolic blood pressure, mean (SD)f 85 (6.6) 83 (8.6) 85 (6.6) 79 (9.5)e 84 (8.1)e 82 (9.0) 81 (9.0) 82 (9.2) 82 (9.0)
≥ 90 (%)f 23.9 24.1 23.9 17.0 29.2 23.2 21.7 26.9 23.2


















Any comorbid condition (% any)c 17.4 13.8 17.4 8.5 20.8 14.7 13.0 19.2 14.7
Medication adherence, % 46.7 35.7 46.7 76.6 85.4 81.1 84.1 73.1 81.1
Physical activity level (moderate/high,
≥ 600 metabolic equivalent minutes/
week), %
39.1 50.0 39.1 70.2 64.6 67.4 69.6 61.5 67.4
Primary care visits, mean (SD)g 4.8 (3.5) 4.3 (3.9) 4.5 (3.7) 3.9
(2.7)e
7.5 (6.6)e 5.7 (5.4) 4.9 (4.2)e 7.7 (7.4)e 5.7 (5.4)
Selected psychosocial variablesf








































Abbreviations: CHW, community health worker; CI, confidence interval; DCAS, Diabetes Care in American Samoa; HbA1c, a measure reflecting average
blood glucose; SD, standard deviation.
a Includes baseline and 12-month follow-up HbA1c levels measured as part of DCAS study.
b Includes 12-month follow-up HbA1c levels measured as part of DCAS study.
c Measured at DCAS enrollment.
d Indicator of potential for contamination across trial arms by church attendance.
e Significant difference by HbA1c measurement category, P < .05. Nonparametric and parametric tests were used as appropriate (eg, t test or Wilcoxon
rank-sum test for continuous variables and χ2 or Fisher’s exact test for categorical variables).
f DCAS enrollment measurement used in DCAS study period analyses. DCAS 12-month follow-up measurement used in subsequent time periods.
g Number of primary care visits during one year before DCAS enrollment used in DCAS study period analysis. Number of primary care visits during DCAS
study period used in subsequent time periods.
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Table 2. Baseline Characteristics of Control Group by Number of HbA1c Measurements, Diabetes Control Intervention,
American Samoa, 2009–2013
Characteristics at Baseline
DCAS Study Period (Usual
Care)a Intervention Periodb
First Year After Intervention
Completion
Number of HbA1c Measurements < 3 ≥ 3 Total < 2 ≥ 2 Total < 2 ≥ 2 Total
Mean number of HbA1c measurements
(95% CI)
2.6 (2.5–2.7) 1.8 (1.6–2.0) 0.7 (0.6–0.8)
Number of participants 90 74 164 66 82 148 116 32 148
Demographicsc


















Married/with partner, % 77.8 78.4 77.8 77.3 78.1 77.3 75.0 87.5 77.7


















Females, % 66.7 63.5 66.7 65.2 65.9 65.2 69.0 53.1 65.5
Employed, % 36.7 44.6 36.7 40.9 42.7 40.9 37.9 56.3 41.9
Church attendance in opposite trial-arm
village, %d
43.3 51.4 43.3 36.4 52.4 36.4 48.3 34.4 45.3
Biological measures












Current daily smoker, %e 6.7 6.8 6.7 10.6 12.2 11.5 12.1 9.4 11.5
Depression symptoms/Patient Health
Questionnaire-9, mean (SD)e
2.4 (1.9) 2.1 (1.3) 2.4 (1.9) 2.2 (2.4) 1.8 (1.4) 2.0 (1.9) 1.9 (1.8) 2.2 (2.2) 2.0 (1.9)
Algorithm risk level: low (quarterly visits
by CHW)c
13.3 10.8 13.3 12.1 12.2 12.2 11.2 15.6 12.2
Algorithm risk level: moderate (monthly
visits by CHW)c
37.8 36.5 37.8 37.9 35.4 36.5 33.6 46.9 36.5
Algorithm risk level: high (weekly visits
by CHW)c
48.9 52.7 48.9 50.0 52.4 51.4 55.2 37.5 51.4




































≥ 140, %e 43.3 37.8 43.3 43.9 29.3 35.8 32.8 46.9 35.8
Diastolic blood pressure, mean (SD)e 85.4 82.1 85.4 84 (10.0) 83 (10.2) 83 83 85 (9.3) 83
Abbreviations: CHW, community health worker; CI, confidence interval; DCAS, Diabetes Care in American Samoa; HbA1c, a measure of average blood
glucose; SD, standard deviation.
a Includes baseline and 12-month follow-up HbA1c levels measured as part of DCAS study.
b Includes 12-month follow-up HbA1c levels measured as part of DCAS study.
c Measured at DCAS enrollment.
d Indicator of potential for contamination across trial arms by church attendance.
e DCAS enrollment measurement used in DCAS study period analyses; DCAS 12-month follow-up measurement used in subsequent time periods.
f Significant difference by HbA1c measurement category, P < .05. Nonparametric and parametric tests were used as appropriate (eg, t test or Wilcoxon
rank-sum test for continuous variables and χ2 or Fisher’s exact test for categorical variables).
g Number of primary care visits during one year before DCAS enrollment used in DCAS study period analysis; number of primary care visits during DCAS
study period used in subsequent time periods.
(continued on next page)
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(continued)
Table 2. Baseline Characteristics of Control Group by Number of HbA1c Measurements, Diabetes Control Intervention,
American Samoa, 2009–2013
Characteristics at Baseline
DCAS Study Period (Usual
Care)a Intervention Periodb
First Year After Intervention
Completion
Number of HbA1c Measurements < 3 ≥ 3 Total < 2 ≥ 2 Total < 2 ≥ 2 Total
(11.8) (9.9) (11.8) (10.1) (10.3) (10.1)
≥ 90, %e 40.0 28.4 40.0 30.3 29.3 29.7 26.7 40.6 29.7


















Any comorbid condition, %c 12.2 8.1 12.2 7.6 9.8 8.8 5.2f 21.9f 8.8
Behavioral measurese
Medication adherence, % 54.4 59.5 54.4 56.9 56.3 56.6 56.6 56.3 56.6
Physical activity level (moderate/high, ≥
600 metabolic equivalent minutes/
week), %
46.7 52.7 46.7 51.5 37.8 43.9 44.8 40.6 43.9
Primary care visits, mean (SD)g 4.3 (3.3) 4.2 (3.9) 4.3 (3.3) 4.2 (3.5) 4.6 (4.1) 4.4 (3.9) 4.1 (3.6) 5.4 (4.6) 4.4 (3.9)
Selected psychosocial variablese








































Abbreviations: CHW, community health worker; CI, confidence interval; DCAS, Diabetes Care in American Samoa; HbA1c, a measure of average blood
glucose; SD, standard deviation.
a Includes baseline and 12-month follow-up HbA1c levels measured as part of DCAS study.
b Includes 12-month follow-up HbA1c levels measured as part of DCAS study.
c Measured at DCAS enrollment.
d Indicator of potential for contamination across trial arms by church attendance.
e DCAS enrollment measurement used in DCAS study period analyses; DCAS 12-month follow-up measurement used in subsequent time periods.
f Significant difference by HbA1c measurement category, P < .05. Nonparametric and parametric tests were used as appropriate (eg, t test or Wilcoxon
rank-sum test for continuous variables and χ2 or Fisher’s exact test for categorical variables).
g Number of primary care visits during one year before DCAS enrollment used in DCAS study period analysis; number of primary care visits during DCAS
study period used in subsequent time periods.
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Table 3. Regression Coefficients From Mixed-Effects Regression Models for HbA1c Over Time, Diabetes Control Interven-
tion, American Samoa, 2009–2013
Variable



















No. of participants in
model n (HbA1c
measurements)
96 (271) 90 (162) 52 (91) 159 (414) 143 (286) 71 (113)


































































































































































Abbreviations: β, regression coefficient; CI, confidence interval; DCAS, Diabetes Care in American Samoa; HbA1c, a measure of average blood glucose.
a Includes baseline and 12-month follow-up HbA1c levels measured as part of DCAS study.
b Includes 12-month follow-up DCAS study HbA1c measurements.
c Measured at DCAS enrollment.
d DCAS enrollment measurement included in DCAS study period models. DCAS 12-month follow-up measurement included in subsequent models.
e Number of primary care visits during one year before DCAS enrollment used in DCAS study period model. Number of primary care visits during DCAS
study period used in subsequent models.
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